Pibrentasvir
Back to searchMolecule Structure
Scientific Name
Pibrentasvir
Description of the Drug
Pibrentasvir is a Hepatitis C NS5A inhibitor used to treat Hepatitis C.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB13878
http://www.drugbank.ca/drugs/DB13878
Brand Name(s)
Not Available
Company Owner(s)
Abbvie Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Nonstructural protein 5A | SINGLE PROTEIN | INHIBITOR | CHEMBL3307224 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL2756579 | SCHEMBL17639956 |
| DrugBank | DB13878 | |
| PubChem: Thomson Pharma | 144215941 | |
| PubChem | 58031952 | |
| Nikkaji | J3.646.121G | |
| BindingDB | 50453100 | |
| DrugCentral | 5244 | |
| ChemicalBook | CB63122682 | |
| Guide to Pharmacology | 11268 | |
| rxnorm | PIBRENTASVIR |
